Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Biochemical Pharmacology|December 22, 2015
Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?Hans-Peter Gerber, Puja Sapra, Frank Loganzo, et al.Mabs|January 15, 2010
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsHans-Peter Gerber, Peter D Senter, Iqbal S GrewalBiochemical Pharmacology|June 21, 2014
Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncologyEdward Rosfjord, Judy Lucas, Gang Li, et al.Natural Product Reports|March 26, 2013
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeuticsHans-Peter Gerber, Frank E Koehn, Robert T AbrahamExpert Opinion on Investigational Drugs|May 24, 2011
Investigational antibody drug conjugates for solid tumorsPuja Sapra, Andrea T Hooper, Christopher J O'Donnell, et al.Biochemical Pharmacology|July 20, 2019
Intracellular targets as source for cleaner targets for the treatment of solid tumorsHans-Peter Gerber, Leah V Sibener, Luke J Lee, et al.Cancer Cell|June 28, 2002
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesisMasahiro Inoue, Jeffrey H Hager, Napoleone Ferrara, et al.Trends in Cancer|March 27, 2020
Identification of Antigenic TargetsHans-Peter Gerber, Leah V Sibener, Luke J Lee, et al.Development (Cambridge, England)|January 28, 2005
Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedbackYoh-Suke Mukouyama, Hans-Peter Gerber, Napoleone Ferrara, et al.Mabs|May 5, 2025
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerationsMiao Wen, Abigail Yu, Young Park, et al.Pageof 8